US approves $3.5 million treatment for hemophilia

US Food and Drug Administration (FDA) has approved the use of Hemgenix for treatment of hemophilia but at the cost $3.5 million per patient, making it the world’s most expensive medicine. Hemgenix would be the first gene therapy to treat…